BTA
Click for more information
0.00% 57.0¢ biota holdings limited

"In addition, Glaxo is developing an intravenous form of Relenza...

  1. outawater
    886 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    26/10/09
    08:31
    Post #: 5829302
    "In addition, Glaxo is developing an intravenous form of Relenza for the sickest patients."

    Not so according to GSK web site - see my previous post Rotahaler Study - follow link - go up one level and you will see that IV program Id No NAI108166 has been closed.
    BTA Price at posting: $2.93 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
NEWS From the Floor question: "Is lithium dead?"
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
NEWS From the Floor: Gold questions answered...
right-arrow Created with Sketch.
RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.